Page last updated: 2024-09-05

sb 203580 and Cancer of Head

sb 203580 has been researched along with Cancer of Head in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, G; Liu, Y; Qiu, YZ; Ren, SL; Su, ZW; Tan, HL; Tian, YQ; Yu, CY; Zhang, X; Zhu, GC1
Bussink, J; Grénman, R; Iida, M; Kaanders, JH; Peeters, WJ; Span, PN; Stegeman, H; van der Kogel, AJ; Verheijen, MM; Wheeler, DL1
D'Silva, NJ; Hyer, JM; Kirkwood, KL; Yu, H; Zhang, X1
Alcolea, S; Alfranca, A; Antón, R; Avilés-Jurado, FX; Camacho, M; León, X; Quer, M; Redondo, JM; Soler, M; Vila, L1
Hebert, C; Nikitakis, NG; Norris, K; Sauk, JJ; Siavash, H; Stewart, J1
Boyd, D; Goepfert, H; Simon, C1
Crowe, DL; Shemirani, B1

Other Studies

7 other study(ies) available for sb 203580 and Cancer of Head

ArticleYear
[EphA2 mediated vascular endothelial growth factor expression via the p38 MAPK signaling pathway in squamous cell carcinoma of the head and neck].
    Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2013, Volume: 48, Issue:3

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Imidazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptor, EphA2; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A

2013
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.
    Molecular cancer, 2013, Nov-05, Volume: 12, Issue:1

    Topics: Antineoplastic Agents; Butadienes; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Dasatinib; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Imidazoles; Isoxazoles; Leflunomide; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Nitriles; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Radiation Tolerance; STAT5 Transcription Factor; STAT6 Transcription Factor; Thiazoles; Tumor Suppressor Proteins

2013
DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma.
    Cancer research, 2014, Dec-15, Volume: 74, Issue:24

    Topics: Animals; Carcinoma, Squamous Cell; Dual Specificity Phosphatase 1; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Imidazoles; Inflammation; Interleukin-1beta; Macrophages; MAP Kinase Signaling System; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; RNA, Messenger

2014
Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2.
    Journal of lipid research, 2012, Volume: 53, Issue:4

    Topics: Arachidonic Acid; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Chemical Fractionation; Coculture Techniques; Culture Media, Conditioned; Cyclooxygenase 2; Dinoprostone; Fibroblasts; Head and Neck Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Interleukin-1; Intramolecular Oxidoreductases; Neovascularization, Pathologic; Prostaglandin-E Synthases; Prostaglandins F; Protein Array Analysis; Protein Stability; Pyridines; Receptors, Interleukin-1; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured

2012
Phenotypic switching of VEGF and collagen XVIII during hypoxia in head and neck squamous carcinoma cells.
    Oral oncology, 2003, Volume: 39, Issue:8

    Topics: Acetylcysteine; Androstadienes; Antimutagenic Agents; Biomarkers; Cell Hypoxia; Cell Line, Tumor; Cobalt; Collagen Type XVIII; Enzyme Inhibitors; Head and Neck Neoplasms; Heat-Shock Proteins; HSP47 Heat-Shock Proteins; Humans; Imidazoles; MAP Kinase Signaling System; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Vascular Endothelial Growth Factor A; Wortmannin

2003
Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
    Cancer research, 1998, Mar-15, Volume: 58, Issue:6

    Topics: Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Collagenases; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Head and Neck Neoplasms; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1998
Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.
    Oral oncology, 2002, Volume: 38, Issue:3

    Topics: Blotting, Western; Carcinoma, Squamous Cell; Cell Hypoxia; Electrophoretic Mobility Shift Assay; Endothelial Growth Factors; Enzyme Induction; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Lymphokines; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002